Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by ledzep4uon Feb 28, 2019 1:40pm
46 Views
Post# 29424118

RE:RE:Canopy's Employee Stock Option Plan (ESOP)

RE:RE:Canopy's Employee Stock Option Plan (ESOP)You should read their financial statements before making that comment. On page 2 of the Statement of Operations there is a line called "Share-based compensation expense" refering to Note 19 (b). For Q3 it was $40m and for the 9 months ending Dec. 31 it was $108.2m. What you may be confusing it with is that it is not a cash related expense (i.e. doesn't impact their cash balance), but it does hit the income statement. 


provester wrote: It seems that you guys are once again misguided with your assumptions about the nature of finance. Employee Stock Option Plan (ESOP) are structured in a way that they do not have an effect on the income statement. They are not expensed, unlike their counterpart, Compensatory Stock Option Plan (CSOP). Think of them as similar to a convertible debt that needs to be excercised at a certain price. Of course at the discretion of the employees, this in turn raises cash for the company, but will have a dilutive effect.


Bullboard Posts